Forbes July 30, 2020
This segment of What’s Ahead warns that, despite its popular appeal, putting price controls on prescription drugs would be an enormous mistake. It takes an immense amount of money to develop a new drug, and if companies can’t recover their costs, they won’t make the necessary investments that will give us new therapies for cancer and countless other afflictions. The idea that forcing drug companies to charge less here will force them to charge more to foreign government-run health systems is dead wrong. If governments...
Today's Sponsors
Today's Sponsor